Crossmark Global Holdings’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,686
Closed -$209K 1398
2018
Q4
$209K Sell
1,686
-2,730
-62% -$450K 0.01% 1268
2018
Q3
$1.08M Sell
4,416
-177
-4% -$40.9K 0.03% 579
2018
Q2
$856K Buy
4,593
+235
+5% +$39.1K 0.02% 669
2018
Q1
$535K Sell
4,358
-480
-10% -$58.6K 0.01% 874
2017
Q4
$576K Buy
4,838
+1,368
+39% +$151K 0.01% 891
2017
Q3
$330K Buy
+3,470
New +$335K 0.01% 1252
2016
Q3
$330K Buy
+3,470
New +$193K 0.01% 1252

Other funds holding INGN

Crossmark Global Holdings's INGN Position: Q1 2019 in Review

Crossmark Global Holdings sold out of Inogen (INGN) in Q1 2019, closing a stake of 1,686 shares — an estimated $209K sold.

Crossmark Global Holdings first reported a position in INGN in Q3 2016 and held it in 7 quarters. The position peaked at $1.08M in Q3 2018. 239 funds tracked by Wall St. Rank hold INGN as of Q1 2019.

  • Crossmark Global Holdings reported no remaining Inogen position as of Q1 2019 after selling out during the quarter.
  • Crossmark Global Holdings sold 1,686 Inogen shares in Q1 2019, an estimated $209K.
  • Crossmark Global Holdings first reported a position in Inogen in Q3 2016 and held it in 7 quarters.
  • Crossmark Global Holdings's Inogen position peaked at $1.08M in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Inogen as of Q1 2019.

Based on Crossmark Global Holdings's 13F filing for Q1 2019, filed 2 May 2019.